Clinical Trials Logo

Foramen Ovale, Patent clinical trials

View clinical trials related to Foramen Ovale, Patent.

Filter by:

NCT ID: NCT04488120 Completed - Clinical trials for Secundum Atrial Septal Defects

Occlutech Septal Occluder (Figulla Flex II) Study

Start date: May 21, 2012
Phase: N/A
Study type: Interventional

The objectives of the study are: - To determine the efficacy of the Figulla Flex II device compared with that of the Amplatzer ASO device for transcatheter closure of secundum atrial septal defects - To determine the safety of the Figulla Flex II device compared with that of the Amplatzer ASO device for transcatheter closure of secundum atrial septal defects This is a randomized, controlled, multi-centre trial of the efficacy and safety of the Occlutech septal occluder (Figulla Flex II) compared to the AGA septal occluder (Amplatzer ASO) for transcatheter closure of secundum atrial septal defects in patients.

NCT ID: NCT04475510 Recruiting - Ischemic Stroke Clinical Trials

Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke

HALTI
Start date: July 8, 2020
Phase: N/A
Study type: Interventional

To determine the safety of antithrombotic treatment discontinuation 12 months following successful transcatheter PFO closure.

NCT ID: NCT04433520 Recruiting - Clinical trials for PFO - Patent Foramen Ovale

Trevisio Post-Approval Study

TrevisioPAS
Start date: September 14, 2020
Phase:
Study type: Observational

A single-arm, non-randomized, multi-center clinical study of the Amplatzer™ Trevisio™ Intravascular Delivery System for facilitating percutaneous, transcatheter implantation of the Amplatzer™ Occluder Devices. NOTE: The enrollment for the VSD cohort is still recruiting (3 subjects at this moment); therefore, the overall status of the study is Recruiting.

NCT ID: NCT04349995 Active, not recruiting - Clinical trials for PFO - Patent Foramen Ovale

Amplatzer PFO Occluder Post-marketing Surveillance Study

PFO PMS Jpn
Start date: October 1, 2019
Phase:
Study type: Observational

The purpose of the Amplatzer PFO Occluder post-marketing clinical use surveillance study is to observe the frequency, type and degree of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect safety and efficacy information for evaluating the results of the clinical use.

NCT ID: NCT04339699 Suspended - Stroke, Ischemic Clinical Trials

NobleStitch EL STITCH Trial is a PFO Comparative Trial

STITCH
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

STITCH - Prospective Multi-Center Comparative Parallel Concurrent Study of the NobleStitch™ EL versus FDA-approved Amplatzer Occluder device for closure of Patent Foramen Ovale to prevent recurrent Ischemic stroke.

NCT ID: NCT04288596 Not yet recruiting - Clinical trials for Patent Foramen Ovale

Canadian Adult Congenital Heart Disease Intervention Registry

C-ACHDiR
Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

The ACHDi Registry study will create a foundational database for adult congenital heart disease interventions. This Pan-Canadian Registry will collect clinical and patient-reported information that will enable the evaluation of care processes and outcomes in five most common ACHDi interventions by enabling prospective and retrospective registry-based studies to answer important clinical practice and policy-relevant questions.

NCT ID: NCT04285918 Recruiting - Cryptogenic Stroke Clinical Trials

Evaluation of Prevalence and Clinical Impact of Atrial Fibrillation in Elderly Patients With Cryptogenic Stroke and High-Risk Patent Foramen Ovale

DefenseElderly
Start date: October 2, 2019
Phase:
Study type: Observational

The purpose of DEFENSE-ELDERLY is to identify the prevalence of AF and evaluate the clinical impact of AF in elderly ESUS patients and no other known sources of stroke besides a high-risk patent foramen ovale, and compare it with elderly ESUS patients without high-risk PFO (no PFO or non-high risk PFOs)

NCT ID: NCT04165161 Completed - Clinical trials for Lung Transplant; Complications

Performance Diagnosis of a Patent Foramen Ovale During Lung Transplantation Using Transesophageal Echocardiography

FOP-TP
Start date: October 30, 2019
Phase: N/A
Study type: Interventional

The investigators hypothesis is that an injection into the inferior vena cava associated with a provocation maneuver should allow to increase the incidence of FOP found by transesophageal echocardiography in a population of patients undergoing lung transplantation.

NCT ID: NCT04105595 Active, not recruiting - Clinical trials for Patent Foramen Ovale

Post Market Registry of the CBSO

CBSO Registry
Start date: March 5, 2020
Phase:
Study type: Observational [Patient Registry]

Multi centre, international, post market registry to monitor the clinical performance and safety of an atrial septal closure device with biodegradable framework in patients with clinically significant atrial septum defect (ASD) or patent foramen ovale (PFO) in routine clinical use

NCT ID: NCT04100135 Active, not recruiting - Migraine Clinical Trials

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study

RELIEF
Start date: February 5, 2021
Phase: N/A
Study type: Interventional

Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief